Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | FAAH | O00519 | 2/20 | 0.37 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL798306 | 0.82 | CNR1 (0.33) | HIF1AMAPTKDM4EMAPK1 | |
| SCHEMBL1556426 | 0.82 | EP300 (0.42) | TSHRFAAHMAPTMAPK1 | |
| SCHEMBL10886696 | 0.80 | EP300 (0.45) | TSHRFAAHMAPTMAPK1 | |
| SCHEMBL10893304 | 0.80 | EP300 (0.45) | TSHRFAAHMAPTMAPK1 | |
| SCHEMBL10531391 | 0.80 | EP300 (0.45) | TSHRFAAHMAPTMAPK1 | |
| SCHEMBL798325 | 0.79 | — | — | |
| SCHEMBL8323964 | 0.78 | KDM4E (0.60) | TSHRHIF1AKDM4EMAPK1ALDH1A1 | |
| SCHEMBL17074293 | 0.77 | ADRA1A (0.52) | TSHRFAAHMAPT | |
| Acetic Acid SCHEMBL29740586 | 0.75 | HIF1A (0.53) | TSHRHIF1AFAAHTRPV1MAPT | |
| SCHEMBL998029 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2162435-B1 | Ionic liquids as electrolytes | INVISTA TECH SARL (CH) | 2013-09-04 | — | — | EP | disclosed |
| US-20120190844-A1 | IONIC LIQUIDS | INVISTA NORTH AMERICA S.A R.L. (US) | 2012-07-26 | — | — | US | disclosed |
| US-8088917-B2 | Ionic liquids | INVISTA NORTH AMERICA S.A R.L. (US) | 2012-01-03 | — | — | US | disclosed |
| EP-2162435-A1 | IONIC LIQUIDS AS ELECTROLYTES | Invista Technologies S.A.R.L. (US) | 2010-03-17 | — | — | EP | disclosed |
| WO-2008150842-A1 | IONIC LIQUIDS AS ELECTROLYTES | INVISTA TECHNOLOGIES S.A.R.L. (US) | 2008-12-11 | — | — | WO | disclosed |
| US-20080296531-A1 | IONIC LIQUIDS | INVISTA NORTH AMERICA S.A R.L. (US) | 2008-12-04 | — | — | US | disclosed |
| EP-0783479-B1 | CONVERSION OF NYLON 6 AND/OR NYLON 6,6 TO ADIPIC ACID | DU PONT (US) | 1999-10-06 | — | — | EP | disclosed |
| EP-0783479-A1 | CONVERSION OF NYLON 6 AND/OR NYLON 6,6 TO ADIPIC ACID | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-07-16 | — | — | EP | disclosed |
| WO-1996010008-A1 | CONVERSION OF NYLON 6 AND/OR NYLON 6,6 TO ADIPIC ACID | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-04-04 | — | — | WO | disclosed |
| US-5468900-A | Conversion of nylon 6 and/or nylon 6,6 to adipic acid | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120190844-A1 | IONIC LIQUIDS | INF2, H1-2, H1-0 | TSHR 1497/4885HIF1A 3278/4885FAAH 934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.